Lataa...
Should we treat acute hepatitis C? A decision and cost-effectiveness analysis
It is not standard practice to treat patients with acute hepatitis C virus (HCV) infection. However, as the incidence of HCV in the United States continues to rise, it may be time to re-evaluate acute HCV management in the era of direct-acting antiviral agents (DAAs). In this study a microsimulation...
Tallennettuna:
| Julkaisussa: | Hepatology |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5826841/ https://ncbi.nlm.nih.gov/pubmed/29059461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.29611 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|